Composite Variability Index and Propofol Remifentanil Anesthesia

• Status: Completed
• Trial end date: 2010-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine if the new Composite Variability Index (CVI) is capable of detecting changing effect compartment concentrations of remifentanil. In addition, it is planed to detect if the change in CVI in response to a standardized painful stimulus is dose-dependent.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Bonn
• Treatments: Remifentanil

Criteria

Inclusion Criteria:

• Patients undergoing surgical procedure in general anesthesia

Exclusion Criteria:

• Pregnancy, drug abuse, cardiac arrhythmia, obesity